Increased incidence of Parkinson disease among relatives of patients with Gaucher disease

被引:104
作者
Halperin, Assaf [1 ]
Elstein, Deborah [1 ]
Zimran, Ani [1 ]
机构
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
关键词
Gaucher disease; Parkinson disease; obligate carrier;
D O I
10.1016/j.bcmd.2006.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a previous study of 99 Ashkenazi Jewish patients with Parkinson disease from Israel who were tested for the six most common mutations for Gaucher disease, 31.3% had at least one Gaucher disease mutation, implying that carrier status per se my be a risk for Parkinson disease. The purpose of this survey was to ascertain the presence of Parkinson disease among Ashkenazi Jewish obligate carriers of Gaucher disease relative to its incidence in a comparable cohort of Ashkenazi Jews who are putatively non-carriers. There was no statistically significant difference in gender or age between the groups (n > 100). Among patients, 27.3% reported having a relative with Parkinson disease while among the controls there was a reported 12.3% which was statistically significant (P=0.05). While based completely on subjective reports in a paper-base questionnaire, the results of this survey implicate a high rate of Parkinson disease among individuals with Gaucher disease mutations. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:426 / 428
页数:3
相关论文
共 20 条
[1]   Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews [J].
Aharon-Peretz, J ;
Rosenbaum, H ;
Gershoni-Baruch, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1972-1977
[2]   Miglustat (NB-DNJ) works as a chaperone for mutated acid β-glucosidase in cells transfected with several Gaucher disease mutations [J].
Alfonso, P ;
Pampín, S ;
Estrada, J ;
Rodríguez-Rey, JC ;
Giraldo, P ;
Sancho, J ;
Pocoví, M .
BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (02) :268-276
[3]   Gaucher's disease with Parkinson's disease - Clinical and pathological aspects [J].
Bembi, B ;
Marsala, SZ ;
Sidransky, E ;
Ciana, G ;
Carrozzi, M ;
Zorzon, M ;
Martini, C ;
Gioulis, M ;
Pittis, MG ;
Capus, L .
NEUROLOGY, 2003, 61 (01) :99-101
[4]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[5]   Neurodegenerative diseases: An overview of environmental risk factors [J].
Brown, RC ;
Lockwood, AH ;
Sonawane, BR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, 113 (09) :1250-1256
[6]   Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders [J].
Butters, TD ;
Mellor, HR ;
Narita, K ;
Dwek, RA ;
Platt, FM .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 358 (1433) :927-945
[7]   Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity [J].
Clark, LN ;
Nicolai, A ;
Afridi, S ;
Harris, J ;
Mejia-Santana, H ;
Strug, L ;
Cote, LJ ;
Louis, ED ;
Andrews, H ;
Waters, C ;
Ford, B ;
Frucht, S ;
Fahn, S ;
Mayeux, R ;
Ottman, R ;
Marder, K .
MOVEMENT DISORDERS, 2005, 20 (01) :100-103
[8]   Parkinsonism among Gaucher disease carriers [J].
Goker-Alpan, O ;
Schiffmann, R ;
LaMarca, ME ;
Nussbaum, RL ;
McInerney-Leo, A ;
Sidransky, E .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (12) :937-940
[9]   The role of early life environmental risk factors in Parkinson disease: what is the evidence? [J].
Logroscino, G .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, 113 (09) :1234-1238
[10]   Glucocerebrosidase mutations in subjects with parkinsonism [J].
Lwin, A ;
Orvisky, E ;
Goker-Alpan, O ;
LaMarca, ME ;
Sidransky, E .
MOLECULAR GENETICS AND METABOLISM, 2004, 81 (01) :70-73